Recurrent and/or metastatic head and neck squamous cell carcinoma
Clinical trials for Recurrent and/or metastatic head and neck squamous cell carcinoma explained in plain language.
Never miss a new study
Get alerted when new Recurrent and/or metastatic head and neck squamous cell carcinoma trials appear
Sign up with your email to follow new studies for Recurrent and/or metastatic head and neck squamous cell carcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill plus chemo shows promise for tough head and neck cancers
Disease control Recruiting nowThis phase 2 trial is testing an oral drug called NRC-2694-A combined with the chemotherapy paclitaxel in people with recurrent or metastatic head and neck squamous cell carcinoma that has worsened after immunotherapy. About 21 adults will receive the combination to see if it shr…
Matched conditions: RECURRENT AND/OR METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase 2 • Sponsor: NATCO Pharma Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Can a PET scan predict if immunotherapy works? new study aims to find out
Knowledge-focused Recruiting nowThis study is testing whether a special PET scan taken 6 weeks after starting pembrolizumab (an immunotherapy drug) can predict how well the drug works at 3, 6, and 9 months in people with advanced head and neck cancer. Researchers will enroll 25 patients whose cancer has returne…
Matched conditions: RECURRENT AND/OR METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA
Sponsor: University of Rome Tor Vergata • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC